Biomerica (BMRA) Receivables (2011 - 2026)

Biomerica has disclosed Receivables across 16 years of filings, most recently posting $1.9 million for Q1 2026.

• Receivables for Q1 2026 came in at $1.9 million, down 25.07% year-over-year; the trailing twelve-month figure through Feb 2026 was $1.9 million (down 25.07% YoY), and the FY2025 annual result was $1.5 million, down 22.22% from the prior year.
• Receivables came in at $1.9 million for Q1 2026 at Biomerica, down from $2.0 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $3.1 million in Q3 2024 to a low of $772000.0 in Q1 2023.
• The 5-year median for Receivables is $1.9 million (2026), against an average of $1.9 million.
• Across the five-year window, Receivables slumped 54.6% in 2022 and soared 209.89% in 2023, its largest moves.
• Biomerica's Receivables stood at $1.4 million in 2022, then surged by 57.14% to $2.2 million in 2023, then rose by 24.26% to $2.7 million in 2024, then retreated by 25.72% to $2.0 million in 2025, then retreated by 3.57% to $1.9 million in 2026.
• The last three Receivables figures came in at $1.9 million (Q1 2026), $2.0 million (Q4 2025), and $2.5 million (Q3 2025), per Business Quant data.